June Yan

June joined Pivotal China as an Operating Partner in 2018. June is a business executive with 20 years of experience working for multinational biopharmaceutical companies in a variety of markets including the United States, China and Asia. Prior to joining Pivotal China, June was the general manager of Celgene China (later acquired by BeiGene). Before that she spent 17 years working at Eli Lilly & Company in different marketing and sales roles in the US and global teams, General Manger in Lilly Hong Kong, Marking Director in Lilly Mid-Sized Asia Markets, and VP of Lilly China leading its Biomedicines Business Unit. With diverse functional and therapeutic experiences, June has the ability to build/grow successful organizations and lead turn-arounds. Her business expertise covers a wide variety of therapeutic areas including specialty care areas such as hematology and oncology, as well as primary care areas including Neuroscience, Diabetes, Infectious Diseases, Osteoporosis, and Men’s Health. June holds an M.B.A. and a M.S. degree in Biochemistry, both from the University of Maryland in the US, and a B.S. degree in Polymer Engineering from Shanghai Jiao Tong University in China.